Novel peptide conjugate vaccines
The present invention provides novel fusion polypeptides and compositions comprising the same. The fusion polypeptides are capable of triggering and/or enhancing an immune response against the peptide sequence of interest contained therein and are thus useful in vaccinating or treating a mammalian s...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
28.02.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides novel fusion polypeptides and compositions comprising the same. The fusion polypeptides are capable of triggering and/or enhancing an immune response against the peptide sequence of interest contained therein and are thus useful in vaccinating or treating a mammalian subject. Kits comprising the fusion polypeptides are also provided.
本发明提供了新的融合多肽及包含其的组合物。融合多肽能够触发和/或增强针对其中包含的感兴趣的肽序列的免疫反应,并因此可用于疫苗接种或治疗哺乳动物受试者。还提供了包含融合多肽的试剂盒。 |
---|---|
Bibliography: | Application Number: CN20238050754 |